You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Continue
COVID-19 Resource Center

News

Getinge finalizes acquisition of Pulsion Medical Systems

Press ReleaseGetinge 2014-02-20

Getinge finalizes acquisition of Pulsion Medical Systems

Getinge has secured 78.55% of the outstanding shares in Pulsion Medical Systems. All conditions precedent stipulated in the offer document have been met and the transaction was completed yesterday. Pulsion will be consolidated in Getinge’s accounts as of March 1 2014.

As communicated earlier, Getinge has issued a public tender offer to acquire all shares in Pulsion Medical Systems SE (“Pulsion”) listed on the German Stock Exchange (Deutsche Börse) against payment of EUR 16.90 per share in cash.

All conditions precedent stipulated in the offer document have been met and the transaction was completed yesterday. The preparation of the Domination and Profit and Loss Transfer Agreement has thus been initiated. Getinge is expected to take control over Pulsion in due course.

According to German Law, the offer can still be accepted by the remaining shareholders until 3 March 2014.

Further information to the public tender offer is set forth in the offer document and is available on www.maquet.com/pulsion-angebot.

For further information please contact:

Ulf Grunander                            
CFO, Getinge Group

Phone: +46 10 335 55 80       
Email:
ulf.grunander@getinge.com

GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act

Files

Share: